Manipal, November 27, 2024: Manipal Academy of Higher Education (MAHE), Manipal, the centre for cGMP, is awarded with the prestigious India Pharma Awards 2024 in recognition for its exceptional contribution to pharmaceutical quality for the second consecutive time. The Centre received special Recognition Award in the category of Excellence in Quality for its pioneering initiative, the Manipal cGMP Museum, which is dedicated to the legacy of Dr TMA Pai, Padmashree Awardee and the visionary founder of Manipal.

The India Pharma Awards 2024 ceremony was held on Day 1 of CPHI-PMEC India at the India Expo Center, Greater Noida, where over 2,000 exhibitors and 50,000 delegates gathered.

The Centre for cGMP submitted a detailed proposal showcasing its world-first digital museum on pharmaceutical quality, which aims to preserve and share the rich history and advancements in the field. The proposal highlighted the Centre's commitment to world-class quality control systems, technological innovations, rigorous training modules, and measurable impacts. It also included documentation of certifications, awards, and recognitions that underscore its industry leadership.

The Centre for cGMP's groundbreaking concept, the Manipal cGMP Museum, was presented in person at the India Pharma Awards 2024 in New Delhi on November 25, 2024. Dr Girish Pai K, Coordinator, and Dr Muddukrishna BS, Co-coordinator, represented MAHE, Manipal, and delivered a compelling 3-minute presentation that highlighted key parameters such as quality control systems, regulatory compliance, internal training, and cost efficiency. The jury members praised the initiative for its innovation and long-lasting societal impact, marking it as a significant contribution to the pharmaceutical sector.

Out of 276 submissions from leading pharmaceutical industries and academic institutions, the Centre for cGMP's proposal stood out, advancing to the final jury stage. The selection process involved a thorough review of submitted documents and a panel of six distinguished jury members. The Centre's initiative was shortlisted based on its excellence in quality, innovation, and societal impact.

Dr Girish Pai K and Dr Muddukrishna BS received the award from Mr Balachandra Barve, Joint Managing Director of Blue Cross Laboratories Ltd., in the presence of industry leaders, pharmaceutical entrepreneurs, and executives from global pharma companies.

This prestigious award reaffirms the Centre for cGMP's leadership in pharmaceutical quality management and its unwavering commitment to excellence in training, innovation, and societal impact. It also highlights the Centre’s role in shaping the future of pharmaceutical education and research on a global scale.